DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the NETFPHARMA (NETFPHARMA) share price today?

NETFPHARMA (NETFPHARMA) is trading at ₹23.36 on the NSE. Source: DocStoX.

NETFPHARMA

NETFPHARMA·NSE

₹23.36▲ +0.00 (+0.00%)

⚠️Trading suspended — last traded ₹23.36 on 19 Jun 2026 (31 days ago). Not a live price.

A steady, established business

52W₹23

₹23100%

Open

₹23.36

High

₹23.36

Low

₹23.36

Prev Close

—

Volume

VWAP

—

Snapshot

Key fundamentals

Market Cap

N/A

P/E Ratio

N/A

P/B Ratio

N/A

EPS

N/A

Book Value

N/A

ROE

N/A

ROCE

N/A

Dividend Yield

N/A

Debt / Equity

N/A

Face Value

₹10.00

52W High

₹23.36

52W Low

₹23.30

Sector

N/A

Industry

N/A

Fairly Valued

None moatHigh uncertainty

Fair value unavailable

/100

Business quality — Solid

Growth 50Profitability 50Efficiency 50Valuation 50

Plain English

Our view

A steady, established business

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

—

ROE

—

ROCE

—

Debt/Eq

—

Mkt Cap

—

P/B

—

EPS

—

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

N/A

No P/E

Growth

N/A

No history

Profitability

N/A

No ROE

Financial health

N/A

No debt data

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

No growth history

Not enough annual history to compute CAGR.

Profile

Forecast

News

Peers

Financials

Growth

Shareholding

No shareholding data

Ownership data is not available for this instrument.

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

(NETFPHARMA) is a listed company trading on the NSE.

Valuation & research

Deep-dive tools with DocStoX's fair-value estimate, ratios and peers.

Fair Value Intrinsic Value DCF Valuation Financial Ratios Peers

Related tools & concepts

Value this stock with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

NETFPHARMA

Key fundamentals

Fair value methods

Investment thesis

Key statistics

Recent changes

News impact

Overview

Trading activity

Technical signals

Growth (CAGR)

Company information

Forecast

News

Peers

Financials

Growth

Shareholding

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Frequently asked questions

Valuation & research

Related tools & concepts

Fair value methods

Investment thesis

Key statistics

Recent changes

News impact

Trading activity

Technical signals

Growth (CAGR)

Company information

Frequently asked questions